Publications from OUS - Dept of Cardiology Ullevaal - Clinical Cardiovascular Research Group
580 publications found
-
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry
Int J Cardiol Heart Vasc, 49, 101302
DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059 -
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvad093, PubMed 38017624 -
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
N Engl J Med (in press)
DOI 10.1056/NEJMoa2310234, PubMed 37952132 -
Anticoagulation in Cancer-associated Thrombosis: How Long Should the Therapy Be?
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvad075, PubMed 37827545 -
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
Int J Mol Sci, 24 (18)
DOI 10.3390/ijms241814143, PubMed 37762446 -
Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy
Am J Ther, 30 (5), e411-e415
DOI 10.1097/MJT.0000000000001622, PubMed 37713684 -
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovasc Diabetol, 22 (1), 233
DOI 10.1186/s12933-023-01963-9, PubMed 37653496 -
OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
N Engl J Med, 389 (16), 1477-1487
DOI 10.1056/NEJMoa2307770, PubMed 37634149 -
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
Clin Res Cardiol (in press)
DOI 10.1007/s00392-023-02268-3, PubMed 37608126 -
Cardiac device infection: removing barriers to timely and adequate treatment
Eur Heart J, 44 (35), 3323-3326
DOI 10.1093/eurheartj/ehad490, PubMed 37529893 -
CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries
JACC Cardiovasc Imaging (in press)
DOI 10.1016/j.jcmg.2023.05.024, PubMed 37498255 -
Evaluation of a Structuralized Sick-Leave Programme Compared with usual Care Sick-Leave Management for Patients after an Acute Myocardial Infarction
J Rehabil Med, 55, jrm4569
DOI 10.2340/jrm.v55.4569, PubMed 37486246 -
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
Nat Rev Cardiol, 20 (12), 830-844
DOI 10.1038/s41569-023-00901-2, PubMed 37474795 -
[PCSK9 inhibitors on reimbursable prescription: who is eligible?]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.23.0191, PubMed 37254976 -
Recurrent pericarditis
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.22.0580, PubMed 37254974 -
Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland
Basic Clin Pharmacol Toxicol, 133 (2), 168-178
DOI 10.1111/bcpt.13902, PubMed 37230945 -
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Eur Heart J Cardiovasc Pharmacother, 9 (4), 353-70 (in press)
DOI 10.1093/ehjcvp/pvad034, PubMed 37169875 -
Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
J Neurol, 270 (8), 4049-4059
DOI 10.1007/s00415-023-11680-8, PubMed 37162578 -
Continue or discontinue aspirin before non-cardiac surgery?
Eur Heart J, 44 (26), 2410
DOI 10.1093/eurheartj/ehad246, PubMed 37155334 -
The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
Chest, 164 (4), 981-991
DOI 10.1016/j.chest.2023.04.042, PubMed 37149257 -
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction
Kardiol Pol, 81 (4), 327-329
DOI 10.33963/KP.a2023.0087, PubMed 37144720 -
Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group
Scand Cardiovasc J, 57 (1), 31-39
DOI 10.1080/14017431.2022.2112071, PubMed 37141087 -
Transvenous lead extractions in a single high-volume center over a 24-year period: High success rate and low complication rate
Heart Rhythm O2, 4 (4), 232-240
DOI 10.1016/j.hroo.2023.01.003, PubMed 37124554 -
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Eur Heart J Cardiovasc Pharmacother, 9 (5), 462-496
DOI 10.1093/ehjcvp/pvad032, PubMed 37120728 -
The roles of cardiac troponins before non-cardiac surgery
Eur Heart J, 44 (23), 2130-2131
DOI 10.1093/eurheartj/ehad226, PubMed 37098747 -
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
Eur Stroke J, 8 (1), 148-156
DOI 10.1177/23969873221123122, PubMed 37021182 -
"I've kept going" - a multisite repeated cross-sectional study of healthcare workers' pride in personal performance during the COVID-19 pandemic
BMC Health Serv Res, 23 (1), 322
DOI 10.1186/s12913-023-09246-5, PubMed 37004056 -
Fully digital self-screening for atrial fibrillation with patch electrocardiogram
Europace, 25 (5)
DOI 10.1093/europace/euad075, PubMed 36945146 -
Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation
BMC Neurol, 23 (1), 115
DOI 10.1186/s12883-023-03155-0, PubMed 36944929 -
RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action
J Am Coll Cardiol, 81 (11), 1130-1132
DOI 10.1016/j.jacc.2022.10.041, PubMed 36922095 -
Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial
EClinicalMedicine, 58, 101875
DOI 10.1016/j.eclinm.2023.101875, PubMed 36915288 -
The second strategic reperfusion early after myocardial infarction (STREAM-2) study
Eur Heart J Acute Cardiovasc Care, 12 (4), 219-221
DOI 10.1093/ehjacc/zuad024, PubMed 36895183 -
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
Eur Heart J Cardiovasc Pharmacother, 9 (3), 271-290
DOI 10.1093/ehjcvp/pvad016, PubMed 36869784 -
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year
Am J Med, 136 (5), 484-488
DOI 10.1016/j.amjmed.2023.01.029, PubMed 36828207 -
[E. Sverre et al. respond]
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.23.0062, PubMed 36811436 -
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
Eur J Neurol, 30 (5), 1352-1363
DOI 10.1111/ene.15746, PubMed 36786305 -
High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
PLoS One, 18 (2), e0281155
DOI 10.1371/journal.pone.0281155, PubMed 36763689 -
[2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]
G Ital Cardiol (Rome), 24 (1 Suppl 1), e1-e102
DOI 10.1714/3956.39326, PubMed 36645369 -
Fibrates: one more lost paradise in lipid treatment
Eur Heart J Cardiovasc Pharmacother, 9 (2), 121
DOI 10.1093/ehjcvp/pvac072, PubMed 36610735 -
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab, 49 (2), 101418
DOI 10.1016/j.diabet.2022.101418, PubMed 36608816 -
Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
JACC Cardiovasc Imaging, 16 (1), 128-129
DOI 10.1016/j.jcmg.2022.07.021, PubMed 36599558 -
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Acute Cardiovasc Care, 11 (12), 939-949
DOI 10.1093/ehjacc/zuac123, PubMed 36574353 -
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
BMJ, 378, e069048
DOI 10.1136/bmj-2021-069048, PubMed 36562446 -
Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
J Clin Med, 11 (24)
DOI 10.3390/jcm11247330, PubMed 36555946 -
The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
Eur Heart J, 44 (5), 336-337
DOI 10.1093/eurheartj/ehac703, PubMed 36527277 -
Pharmacological treatment of CVD
Eur Heart J Cardiovasc Pharmacother, 9 (1), 1-3
DOI 10.1093/ehjcvp/pvac068, PubMed 36519600 -
[Checkpoint inhibitor-induced myocarditis]
Tidsskr Nor Laegeforen, 142 (18)
DOI 10.4045/tidsskr.21.0817, PubMed 36511752 -
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomed Pharmacother, 158, 114064
DOI 10.1016/j.biopha.2022.114064, PubMed 36495662 -
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Eur Heart J, 44 (4), 262-279
DOI 10.1093/eurheartj/ehac515, PubMed 36477865 -
To treat or not to treat
Eur Heart J Cardiovasc Pharmacother, 8 (8), 754-755
DOI 10.1093/ehjcvp/pvac062, PubMed 36458860 -
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
Eur Heart J Open, 2 (6), oeac070
DOI 10.1093/ehjopen/oeac070, PubMed 36440353 -
Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area
Open Heart, 9 (2)
DOI 10.1136/openhrt-2022-002159, PubMed 36428084 -
Personalised cardiovascular disease prevention in the new guidelines
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0508, PubMed 36416647 -
The link between liver fat and cardiometabolic diseases is highlighted by genome-wide association study of MRI-derived measures of body composition
Commun Biol, 5 (1), 1271
DOI 10.1038/s42003-022-04237-4, PubMed 36402844 -
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data
J Cardiovasc Magn Reson, 24 (1), 53
DOI 10.1186/s12968-022-00888-8, PubMed 36336693 -
Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting
BMC Health Serv Res, 22 (1), 1274
DOI 10.1186/s12913-022-08697-6, PubMed 36271364 -
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020
ESC Heart Fail, 10 (1), 405-415
DOI 10.1002/ehf2.14206, PubMed 36266969 -
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
Eur Heart J Acute Cardiovasc Care, 11 (11), 865-874
DOI 10.1093/ehjacc/zuac107, PubMed 36226746 -
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
Eur Heart J, 43 (37), 3578-3588
DOI 10.1093/eurheartj/ehac426, PubMed 36208161 -
The new 2022 ESC Guidelines on Cardio-oncology and their impact on the Acute Cardiovascular Care Society
Eur Heart J Acute Cardiovasc Care, 11 (11), 844-849
DOI 10.1093/ehjacc/zuac129, PubMed 36205095 -
Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding
Eur Heart J Cardiovasc Pharmacother, 8 (7), 645-647
DOI 10.1093/ehjcvp/pvac048, PubMed 36172980 -
Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19
Eur Heart J Open, 2 (5), oeac052
DOI 10.1093/ehjopen/oeac052, PubMed 36071696 -
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care
Eur Heart J Qual Care Clin Outcomes, 9 (4), 331-341
DOI 10.1093/ehjqcco/qcac057, PubMed 36069905 -
Prevention is still the key to success
Eur Heart J Cardiovasc Pharmacother, 8 (6), 537-538
DOI 10.1093/ehjcvp/pvac046, PubMed 36057770 -
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
Lancet Digit Health, 4 (10), e757-e764
DOI 10.1016/S2589-7500(22)00151-0, PubMed 36050271 -
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
J Am Coll Cardiol, 80 (12), 1130-1143
DOI 10.1016/j.jacc.2022.06.037, PubMed 36050227 -
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
Circulation, 146 (15), 1109-1119
DOI 10.1161/CIRCULATIONAHA.122.061620, PubMed 36031810 -
Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
BMC Prim Care, 23 (1), 214
DOI 10.1186/s12875-022-01824-6, PubMed 36008778 -
A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
Cardiovasc Drugs Ther (in press)
DOI 10.1007/s10557-022-07373-5, PubMed 36001200 -
Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet
Int J Clin Pharmacol Ther, 60 (10), 430-438
DOI 10.5414/CP204271, PubMed 35979901 -
Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary Syndrome
Am J Med, 135 (11), 1342-1348
DOI 10.1016/j.amjmed.2022.07.022, PubMed 35977606 -
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
Eur Heart J, 43 (37), 3512-3527
DOI 10.1093/eurheartj/ehac294, PubMed 35925556 -
Toward personalized medicine for cardiovascular pharmacotherapy
Eur Heart J, 43 (45), 4719-4721
DOI 10.1093/eurheartj/ehac413, PubMed 35924414 -
Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries
Eur Heart J Open, 2 (4), oeac042
DOI 10.1093/ehjopen/oeac042, PubMed 35919580 -
Focus on optimizing treatment of coronary heart disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), 431-433
DOI 10.1093/ehjcvp/pvac039, PubMed 35856265 -
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Eur Heart J Cardiovasc Pharmacother, 8 (7), 738-751
DOI 10.1093/ehjcvp/pvac040, PubMed 35848895 -
[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]
G Ital Cardiol (Rome), 23 (6 Suppl 1), e3-e115
DOI 10.1714/3808.37926, PubMed 35708476 -
Focus on different aspects of atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 8 (4), 323-324
DOI 10.1093/ehjcvp/pvac035, PubMed 35674202 -
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial
JAMA Cardiol, 7 (7), 682-689
DOI 10.1001/jamacardio.2022.1166, PubMed 35612866 -
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Rev Esp Cardiol (Engl Ed), 75 (5), 429
DOI 10.1016/j.rec.2022.04.003, PubMed 35525570 -
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol, 80 (7-8), 741-749
DOI 10.33963/KP.a2022.0117, PubMed 35521719 -
Future of antithrombotic therapy for heart failure with coronary artery disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), e25
DOI 10.1093/ehjcvp/pvac030, PubMed 35521703 -
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
JACC CardioOncol, 4 (1), 19-37
DOI 10.1016/j.jaccao.2022.01.101, PubMed 35492815 -
Coagulation factors XI and XII as possible targets for anticoagulant therapy
Thromb Res, 214, 53-62
DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644 -
Gene expression of fibrinolytic markers in coronary thrombi
Thromb J, 20 (1), 23
DOI 10.1186/s12959-022-00383-1, PubMed 35488283 -
Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
Scand J Med Sci Sports, 32 (8), 1170-1181
DOI 10.1111/sms.14172, PubMed 35460300 -
New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
Eur Heart J Cardiovasc Pharmacother, 8 (3), 213-215
DOI 10.1093/ehjcvp/pvac019, PubMed 35435962 -
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
PLoS One, 17 (4), e0266615
DOI 10.1371/journal.pone.0266615, PubMed 35404972 -
Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
Open Heart, 9 (1)
DOI 10.1136/openhrt-2021-001934, PubMed 35387862 -
Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1-Hour Algorithm in a Low-Risk Population
J Am Heart Assoc, 11 (7), e024927
DOI 10.1161/JAHA.121.024927, PubMed 35352564 -
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
BMC Cardiovasc Disord, 22 (1), 88
DOI 10.1186/s12872-022-02522-y, PubMed 35247979 -
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Eur J Heart Fail, 24 (5), 782-790
DOI 10.1002/ejhf.2468, PubMed 35239245 -
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
PLoS One, 17 (2), e0264628
DOI 10.1371/journal.pone.0264628, PubMed 35213675 -
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial
Open Heart, 9 (1)
DOI 10.1136/openhrt-2021-001892, PubMed 35172988 -
Do We Really Need Aspirin Loading for STEMI?
Cardiovasc Drugs Ther, 36 (6), 1221-1238
DOI 10.1007/s10557-022-07327-x, PubMed 35171384 -
Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial
JAMA Cardiol, 7 (4), 435-444
DOI 10.1001/jamacardio.2021.5916, PubMed 35171199 -
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
Acta Neurol Scand, 145 (5), 641-646
DOI 10.1111/ane.13590, PubMed 35146751 -
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (4), 406-419
DOI 10.1093/ehjcvp/pvac005, PubMed 35092425 -
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
J Womens Health (Larchmt), 31 (3), 310-320
DOI 10.1089/jwh.2021.0326, PubMed 35049355 -
Optimizing individual heart failure treatment
Eur Heart J Cardiovasc Pharmacother, 8 (2), 105-107
DOI 10.1093/ehjcvp/pvab087, PubMed 35039827 -
Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
JACC Cardiovasc Imaging, 15 (4), 607-625
DOI 10.1016/j.jcmg.2021.11.008, PubMed 35033498 -
The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool
Curr Cardiol Rep, 24 (2), 109-118
DOI 10.1007/s11886-021-01628-7, PubMed 35028816 -
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials
Clin Cardiol, 45 (1), 101-109
DOI 10.1002/clc.23765, PubMed 35019175 -
Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient
Eur Heart J Cardiovasc Pharmacother, 8 (1), 1-3
DOI 10.1093/ehjcvp/pvab078, PubMed 34984441 -
Cardioprotection in breast cancer patients: one size fits all?
Eur Heart J, 43 (27), 2570-2572
DOI 10.1093/eurheartj/ehab810, PubMed 34951626 -
High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001869, PubMed 34933964 -
Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population-based cohort study in Norway
Fundam Clin Pharmacol, 36 (3), 563-571
DOI 10.1111/fcp.12744, PubMed 34904750 -
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovasc Res, 118 (6), 1385-1412
DOI 10.1093/cvr/cvab342, PubMed 34864874 -
MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study
J Cardiovasc Magn Reson, 23 (1), 137
DOI 10.1186/s12968-021-00824-2, PubMed 34857009 -
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
J Intern Med, 291 (3), 327-337
DOI 10.1111/joim.13409, PubMed 34820922 -
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis
Ann Intern Med, 175 (1), 101-113
DOI 10.7326/M21-1499, PubMed 34807719 -
Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology
J Healthc Eng, 2021, 5230947
DOI 10.1155/2021/5230947, PubMed 34765102 -
Unsolved pharmacological issues with cardiology
Eur Heart J Cardiovasc Pharmacother, 7 (6), 461-462
DOI 10.1093/ehjcvp/pvab077, PubMed 34734246 -
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
BMJ, 375, e066450
DOI 10.1136/bmj-2021-066450, PubMed 34706884 -
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur J Prev Cardiol, 29 (1), 5-115
DOI 10.1093/eurjpc/zwab154, PubMed 34558602 -
More knowledge about atrial fibrillation, still we need to learn
Eur Heart J Cardiovasc Pharmacother, 7 (5), 361-362
DOI 10.1093/ehjcvp/pvab067, PubMed 34545933 -
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis
Clin Res Cardiol, 111 (4), 428-439
DOI 10.1007/s00392-021-01913-z, PubMed 34498169 -
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 100-103
DOI 10.1093/ehjcvp/pvab063, PubMed 34463331 -
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur Heart J, 42 (34), 3227-3337
DOI 10.1093/eurheartj/ehab484, PubMed 34458905 -
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
Eur Heart J Acute Cardiovasc Care, 10 (8), 947-959
DOI 10.1093/ehjacc/zuab056, PubMed 34453829 -
Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001720, PubMed 34426527 -
Icons in Cardiology
Cardiology, 146 (6), 667
DOI 10.1159/000519019, PubMed 34412055 -
The Establishment of the Nordic Cardio-Oncology Society
JACC CardioOncol, 2 (2), 333-335
DOI 10.1016/j.jaccao.2020.04.004, PubMed 34396242 -
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
EBioMedicine, 70, 103511
DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947 -
Adherence to pharmacological treatment: how can we improve?
Eur Heart J Cardiovasc Pharmacother, 7 (4), 261-262
DOI 10.1093/ehjcvp/pvab049, PubMed 34298551 -
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?
Am J Cardiovasc Drugs, 22 (2), 113-115
DOI 10.1007/s40256-021-00488-4, PubMed 34254254 -
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
Cardiovasc Drugs Ther, 36 (3), 525-532
DOI 10.1007/s10557-021-07224-9, PubMed 34245446 -
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
Eur Heart J Qual Care Clin Outcomes, 8 (5), 577-587
DOI 10.1093/ehjqcco/qcab048, PubMed 34244745 -
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
PLoS One, 16 (7), e0253247
DOI 10.1371/journal.pone.0253247, PubMed 34242246 -
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (3), 302-310
DOI 10.1093/ehjcvp/pvab048, PubMed 34180504 -
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
PLoS One, 16 (6), e0253793
DOI 10.1371/journal.pone.0253793, PubMed 34170978 -
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused
Eur J Intern Med, 90, 125-126
DOI 10.1016/j.ejim.2021.05.009, PubMed 34090747 -
Oral Anticoagulation Therapy for Venous Thromboembolism in Norway: Time Trends and Treatment Patterns
Clin Ther, 43 (7), 1179-1190.e3
DOI 10.1016/j.clinthera.2021.04.017, PubMed 34083030 -
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
Eur Heart J Acute Cardiovasc Care, 10 (5), 570-583
DOI 10.1093/ehjacc/zuab015, PubMed 34057173 -
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
EuroIntervention, 17 (4), e274-e286
DOI 10.4244/EIJY21M05_01, PubMed 34057071 -
Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)
Front Neurol, 12, 650695
DOI 10.3389/fneur.2021.650695, PubMed 34054695 -
Different aspects of giving the optimal antiplatelet treatment
Eur Heart J Cardiovasc Pharmacother, 7 (3), 169-170
DOI 10.1093/ehjcvp/pvab037, PubMed 34023878 -
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Circulation, 143 (25), 2431-2440
DOI 10.1161/CIRCULATIONAHA.121.054698, PubMed 33993702 -
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
Heart, 108 (5), 345-352
DOI 10.1136/heartjnl-2020-318753, PubMed 33975877 -
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 7 (6), 557-567
DOI 10.1093/ehjcvp/pvab038, PubMed 33956964 -
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation
Eur J Intern Med, 88, 21-22
DOI 10.1016/j.ejim.2021.04.008, PubMed 33934970 -
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
JACC Cardiovasc Interv, 14 (7), 768-780
DOI 10.1016/j.jcin.2021.02.022, PubMed 33826497 -
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
Ann Med, 53 (1), 485-494
DOI 10.1080/07853890.2021.1893897, PubMed 33818226 -
Antiplatelet treatment in coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 7 (2), 81-82
DOI 10.1093/ehjcvp/pvab015, PubMed 33720341 -
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
Eur Heart J Qual Care Clin Outcomes, 8 (3), 307-314
DOI 10.1093/ehjqcco/qcaa098, PubMed 33710273 -
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 85-99
DOI 10.1093/ehjcvp/pvab018, PubMed 33638977 -
Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study
BMJ Open, 11 (2), e046024
DOI 10.1136/bmjopen-2020-046024, PubMed 33627355 -
Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis
Eur Heart J Acute Cardiovasc Care, 10 (3), 343-355
DOI 10.1093/ehjacc/zuaa025, PubMed 33620437 -
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries
Eur Heart J Qual Care Clin Outcomes, 8 (4), 429-436
DOI 10.1093/ehjqcco/qcab013, PubMed 33605415 -
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
Eur Heart J Acute Cardiovasc Care, 10 (2), 224-233
DOI 10.1093/ehjacc/zuaa037, PubMed 33550362 -
Is RBBB the new LBBB? Are we going to repeat the same mistakes?
J Electrocardiol, 65, 34-36
DOI 10.1016/j.jelectrocard.2020.12.010, PubMed 33477070 -
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Atherosclerosis, 319, 51-61
DOI 10.1016/j.atherosclerosis.2020.12.013, PubMed 33476944 -
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Circulation, 143 (12), 1215-1223
DOI 10.1161/CIRCULATIONAHA.120.051020, PubMed 33461308 -
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
Thromb Haemost, 121 (6), 716-730
DOI 10.1055/s-0040-1721665, PubMed 33412613 -
Atrial fibrillation in registries
Eur Heart J Cardiovasc Pharmacother, 7 (1), 1-2
DOI 10.1093/ehjcvp/pvaa142, PubMed 33367509 -
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother, 8 (3), 227-235
DOI 10.1093/ehjcvp/pvaa140, PubMed 33367487 -
The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause - aims, function and structure: Position paper of the Association for Acute CardioVascular Care of the European Society of Cardiology (AVCV), European Association of Percutaneous Coronary Interventions (EAPCI), European Heart Rhythm Association (EHRA), European Resuscitation Council (ERC), European Society for Emergency Medicine (EUSEM) and European Society of Intensive Care Medicine (ESICM)
Eur Heart J Acute Cardiovasc Care, 9 (4_suppl), S193-S202
DOI 10.1177/2048872620963492, PubMed 33327761 -
Music therapy as an adjunct in cardiac device lead extraction procedures: A randomized controlled trial
Appl Nurs Res, 56, 151376
DOI 10.1016/j.apnr.2020.151376, PubMed 33280783 -
Focus on blood pressure and risk factor intervention
Eur Heart J Cardiovasc Pharmacother, 6 (6), 339-340
DOI 10.1093/ehjcvp/pvaa130, PubMed 33197927 -
Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis
Echocardiography, 38 (1), 31-38
DOI 10.1111/echo.14916, PubMed 33146452 -
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis
J Cardiovasc Pharmacol, 77 (1), 87-93
DOI 10.1097/FJC.0000000000000922, PubMed 33136764 -
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
Eur Heart J Cardiovasc Pharmacother, 7 (5), 453-459
DOI 10.1093/ehjcvp/pvaa126, PubMed 33135079 -
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
Eur Heart J, 41 (44), 4245-4255
DOI 10.1093/eurheartj/ehaa649, PubMed 33051646 -
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
Curr Heart Fail Rep, 17 (6), 397-408
DOI 10.1007/s11897-020-00486-8, PubMed 32979150 -
The perils of data sharing, meta-analyses, and estimating cardiovascular risk
Eur Heart J Cardiovasc Pharmacother, 7 (3), e55-e57
DOI 10.1093/ehjcvp/pvaa109, PubMed 32941601 -
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
Eur Heart J Cardiovasc Pharmacother, 8 (2), 187-210
DOI 10.1093/ehjcvp/pvaa108, PubMed 32941594 -
Minimizing bleeding events
Eur Heart J Cardiovasc Pharmacother, 6 (5), 271-272
DOI 10.1093/ehjcvp/pvaa100, PubMed 32932523 -
Cardioversion Safety - Are We Doing Enough?
Cardiology, 145 (11), 740-745
DOI 10.1159/000509343, PubMed 32898849 -
The cancer patient and cardiology
Eur J Heart Fail, 22 (12), 2290-2309
DOI 10.1002/ejhf.1985, PubMed 32809231 -
Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study
Open Heart, 7 (2)
DOI 10.1136/openhrt-2020-001296, PubMed 32719074 -
Incidence and prevalence of venous thromboembolism in Norway 2010-2017
Thromb Res, 195, 165-168
DOI 10.1016/j.thromres.2020.07.011, PubMed 32707359 -
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
Future Cardiol, 17 (1), 19-38
DOI 10.2217/fca-2020-0014, PubMed 32696663 -
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?
Cardiovasc Drugs Ther, 34 (6), 865-870
DOI 10.1007/s10557-020-07039-0, PubMed 32671603 -
Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?
Eur Heart J Cardiovasc Pharmacother, 6 (4), 201-202
DOI 10.1093/ehjcvp/pvaa075, PubMed 32668002 -
Intensification of antithrombotic therapy for chronic atherosclerosis
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0066, PubMed 32602309 -
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Ann Noninvasive Electrocardiol, 25 (6), e12784
DOI 10.1111/anec.12784, PubMed 32592427 -
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Circulation, 142 (7), 621-642
DOI 10.1161/CIRCULATIONAHA.120.046361, PubMed 32546049 -
Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016
ESC Heart Fail, 7 (4), 1917-1926
DOI 10.1002/ehf2.12773, PubMed 32530563 -
Adherence to guidelines, compliance to treatment, and treatment quality
Eur Heart J Cardiovasc Pharmacother, 4 (4), 189-190
DOI 10.1093/ehjcvp/pvy033, PubMed 32420591 -
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
J Clin Lipidol, 14 (3), 339-345
DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822 -
Focus on subpopulations of atrial fibrillation patients
Eur Heart J Cardiovasc Pharmacother, 6 (3), 131-132
DOI 10.1093/ehjcvp/pvaa034, PubMed 32412082 -
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Eur Heart J, 41 (19), 1839-1851
DOI 10.1093/eurheartj/ehaa381, PubMed 32405641 -
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
EuroIntervention, 16 (3), 233-246
DOI 10.4244/EIJY20M05_01, PubMed 32404302 -
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size
Eur Heart J Acute Cardiovasc Care, 9 (4), 302-312
DOI 10.1177/2048872620923641, PubMed 32403934 -
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Heart Fail Rev, 26 (6), 1421-1435
DOI 10.1007/s10741-020-09954-8, PubMed 32314085 -
Eivind Berge, MD, PhD, 1964-2020: Cardiologist Who Was Fighting Stroke
Stroke, 51 (5), 1353-1355
DOI 10.1161/STROKEAHA.120.029351, PubMed 32200755 -
Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
Sci Rep, 10 (1), 5007
DOI 10.1038/s41598-020-61971-7, PubMed 32193509 -
Pharmacy-dispensed drugs for secondary prevention after myocardial infarction
Tidsskr Nor Laegeforen, 140 (4)
DOI 10.4045/tidsskr.19.0416, PubMed 32192264 -
Lipids and antithrombotic treatment
Eur Heart J Cardiovasc Pharmacother, 6 (2), 71
DOI 10.1093/ehjcvp/pvaa014, PubMed 32176294 -
Incidence, risk factors and outcome of young patients with myocardial infarction
Heart, 106 (18), 1420-1426
DOI 10.1136/heartjnl-2019-316067, PubMed 32111640 -
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur Heart J Cardiovasc Pharmacother, 7 (2), 125-140
DOI 10.1093/ehjcvp/pvaa009, PubMed 32049278 -
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study
Cerebrovasc Dis Extra, 10 (1), 11-20
DOI 10.1159/000504529, PubMed 32028277 -
Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
Eur Heart J Acute Cardiovasc Care, 9 (4), 348-357
DOI 10.1177/2048872619894255, PubMed 31976747 -
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
Eur Heart J Acute Cardiovasc Care, 9 (1), 76-89
DOI 10.1177/2048872619885346, PubMed 31958018 -
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
J Am Coll Cardiol, 75 (2), 133-144
DOI 10.1016/j.jacc.2019.10.057, PubMed 31948641 -
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
Eur Heart J Cardiovasc Pharmacother, 6 (2), 75-85
DOI 10.1093/ehjcvp/pvz086, PubMed 31942972 -
Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study
J Med Internet Res, 22 (1), e15445
DOI 10.2196/15445, PubMed 31909717 -
Focus on pharma in acute coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 6 (1), 1-2
DOI 10.1093/ehjcvp/pvz074, PubMed 31909430 -
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Am Heart J, 221, 1-8
DOI 10.1016/j.ahj.2019.10.013, PubMed 31896036 -
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
Atherosclerosis, 296, 74-82
DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625 -
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
Mediators Inflamm, 2019, 7816491
DOI 10.1155/2019/7816491, PubMed 31772506 -
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
Europace, 22 (2), 195-204
DOI 10.1093/europace/euz292, PubMed 31747004 -
Experiences of informal caregivers after cardiac surgery: a systematic integrated review of qualitative and quantitative studies
BMJ Open, 9 (11), e032751
DOI 10.1136/bmjopen-2019-032751, PubMed 31719093 -
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS
Am Heart J, 218, 57-65
DOI 10.1016/j.ahj.2019.08.016, PubMed 31707329 -
Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
Cardiology, 144 (3-4), 79-89
DOI 10.1159/000503442, PubMed 31689705 -
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
BMC Med, 17 (1), 198
DOI 10.1186/s12916-019-1428-0, PubMed 31679516 -
Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium
Eur J Prev Cardiol, 27 (3), 234-243
DOI 10.1177/2047487319877078, PubMed 31619084 -
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Circulation, 140 (23), 1921-1932
DOI 10.1161/CIRCULATIONAHA.119.043308, PubMed 31557056 -
European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723
Eur Heart J Cardiovasc Pharmacother, 5 (4), 183-184
DOI 10.1093/ehjcvp/pvz041, PubMed 31531677 -
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Eur Heart J, 41 (3), 407-477
DOI 10.1093/eurheartj/ehz425, PubMed 31504439 -
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?
Am J Med, 133 (3), 347-351
DOI 10.1016/j.amjmed.2019.07.046, PubMed 31442391 -
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon
Cardiovasc Drugs Ther, 33 (5), 589-597
DOI 10.1007/s10557-019-06901-0, PubMed 31418141 -
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 6 (2), 104-114
DOI 10.1093/ehjcvp/pvz033, PubMed 31397840 -
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Eur Heart J Cardiovasc Pharmacother, 6 (2), 86-93
DOI 10.1093/ehjcvp/pvz036, PubMed 31392312 -
Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation
Catheter Cardiovasc Interv, 95 (6), 1171-1175
DOI 10.1002/ccd.28419, PubMed 31379116 -
Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials
Heart Fail Rev, 25 (2), 161-171
DOI 10.1007/s10741-019-09832-y, PubMed 31364027 -
The myth of 'stable' coronary artery disease
Nat Rev Cardiol, 17 (1), 9-21
DOI 10.1038/s41569-019-0233-y, PubMed 31358978 -
Challenging Anticoagulation in Advanced Renal Failure
Am J Med, 132 (11), 1258-1259
DOI 10.1016/j.amjmed.2019.07.002, PubMed 31356767 -
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
PLoS One, 14 (7), e0220079
DOI 10.1371/journal.pone.0220079, PubMed 31335881 -
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox
Clin Cardiol, 42 (10), 1028-1040
DOI 10.1002/clc.23232, PubMed 31317575 -
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF
Am J Med, 132 (12), 1431-1440.e7
DOI 10.1016/j.amjmed.2019.06.008, PubMed 31306621 -
Heat Stress Impacts on Cardiac Mortality in Nepali Migrant Workers in Qatar
Cardiology, 143 (1), 37-48
DOI 10.1159/000500853, PubMed 31302648 -
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
Eur Heart J Cardiovasc Pharmacother, 6 (2), 97-103
DOI 10.1093/ehjcvp/pvz029, PubMed 31298686 -
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Am Heart J, 215, 83-90
DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604 -
Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients - data from the CHILL-MI, MITOCARE and SOCCER trials
BMC Cardiovasc Disord, 19 (1), 161
DOI 10.1186/s12872-019-1139-7, PubMed 31269907 -
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design
Eur Stroke J, 4 (2), 172-180
DOI 10.1177/2396987319837089, PubMed 31259265 -
Antiplatelet treatment in acute coronary syndrome. Still an issue
Eur Heart J Cardiovasc Pharmacother, 5 (3), 125-126
DOI 10.1093/ehjcvp/pvz018, PubMed 31210265 -
Long-term cardiovascular morbidity following hyperemesis gravidarum: A Norwegian nationwide cohort study
PLoS One, 14 (6), e0218051
DOI 10.1371/journal.pone.0218051, PubMed 31188868 -
Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis
Heart, 105 (21), 1629-1633
DOI 10.1136/heartjnl-2018-314462, PubMed 31154431 -
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther, 26 (6), e671-e678
DOI 10.1097/MJT.0000000000000883, PubMed 31145139 -
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Eur Heart J Cardiovasc Pharmacother, 5 (3), 171-180
DOI 10.1093/ehjcvp/pvz016, PubMed 31119266 -
"Doctor, Should I Keep Taking an Aspirin a Day?"
N Engl J Med, 380 (20), 1967-1970
DOI 10.1056/NEJMclde1903004, PubMed 31091380 -
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries
Clin Chem, 65 (8), 1023-1030
DOI 10.1373/clinchem.2018.301085, PubMed 31072836 -
ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries
Int J Cardiol, 287, 128-131
DOI 10.1016/j.ijcard.2019.04.028, PubMed 31003795 -
Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction
Eur J Prev Cardiol, 26 (13), 1373-1382
DOI 10.1177/2047487319841940, PubMed 30966816 -
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease
BMC Med, 17 (1), 72
DOI 10.1186/s12916-019-1306-9, PubMed 30943979 -
Late Pseudoaneurysm After Access Site Closure with Manta in Transfemoral Aortic Valve Implantation
EJVES Short Rep, 42, 34-36
DOI 10.1016/j.ejvssr.2018.10.003, PubMed 30931405 -
Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease
BMC Cardiovasc Disord, 19 (1), 71
DOI 10.1186/s12872-019-1062-y, PubMed 30922234 -
European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
Eur Heart J Cardiovasc Pharmacother, 5 (2), 59
DOI 10.1093/ehjcvp/pvz009, PubMed 30874813 -
Unsolved issues in oral anticoagulation treatment in atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 5 (2), 60-61
DOI 10.1093/ehjcvp/pvz008, PubMed 30874812 -
Editor's Note
Cardiology, 142 (1), 1
DOI 10.1159/000497089, PubMed 30852568 -
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
Eur Heart J Suppl, 21 (Suppl A), A28-A33
DOI 10.1093/eurheartj/suy035, PubMed 30837802 -
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Int J Cardiol, 289, 83-90
DOI 10.1016/j.ijcard.2019.01.109, PubMed 30827731 -
Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implement
Pol Arch Intern Med, 129 (2), 78-79
DOI 10.20452/pamw.4467, PubMed 30816102 -
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
Heart, 105 (16), 1252-1259
DOI 10.1136/heartjnl-2018-314256, PubMed 30792238 -
On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
Eur Heart J, 40 (19), 1501-1503
DOI 10.1093/eurheartj/ehz014, PubMed 30753396 -
Medical Misinformation: Vet the Message!
J Cardiovasc Pharmacol, 73 (2), 61-62
DOI 10.1097/FJC.0000000000000648, PubMed 30730472 -
Health Care Professionals' Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey
J Med Internet Res, 21 (2), e10362
DOI 10.2196/10362, PubMed 30724744 -
Medical misinformation: Vet the message!
Heart Rhythm, 16 (3), 332-333
DOI 10.1016/j.hrthm.2018.12.030, PubMed 30703343 -
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
DOI 10.1093/ehjcvp/pvz005, PubMed 30698668 -
Medical misinformation: vet the message!
Eur Heart J Qual Care Clin Outcomes, 5 (2), 83-84
DOI 10.1093/ehjqcco/qcy057, PubMed 30689789 -
Medical misinformation: vet the message!
Eur Heart J Cardiovasc Pharmacother, 5 (2), 62-63
DOI 10.1093/ehjcvp/pvz001, PubMed 30689786 -
Medical misinformation: vet the message!
Cardiovasc Res, 115 (14), e187-8 (in press)
DOI 10.1093/cvr/cvz007, PubMed 30689762 -
Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide
CVIR Endovasc, 1 (1), 20
DOI 10.1186/s42155-018-0026-0, PubMed 30652151 -
Old and new drugs in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (1), 1-2
DOI 10.1093/ehjcvp/pvy046, PubMed 30615170 -
New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Open Heart, 5 (2), e000931
DOI 10.1136/openhrt-2018-000931, PubMed 30613418 -
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196 -
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
Am Heart J, 208, 123-131
DOI 10.1016/j.ahj.2018.09.017, PubMed 30579505 -
Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study
BJGP Open, 2 (3), bjgpopen18X101596
DOI 10.3399/bjgpopen18X101596, PubMed 30564729 -
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
J Cardiovasc Pharmacol Ther, 24 (3), 215-224
DOI 10.1177/1074248418812167, PubMed 30563349 -
Increases in Circulating Cardiac Troponin Are Not Always Associated with Myocardial Cell Death
Clin Lab, 64 (11)
DOI 10.7754/Clin.Lab.2018.180615, PubMed 30549980 -
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
Am Heart J, 208, 37-46
DOI 10.1016/j.ahj.2018.10.005, PubMed 30530121 -
Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
Am J Med, 132 (3), 374-381.e1
DOI 10.1016/j.amjmed.2018.11.010, PubMed 30503881 -
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
Open Heart, 5 (2), e000908
DOI 10.1136/openhrt-2018-000908, PubMed 30487982 -
MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
PLoS One, 13 (11), e0206723
DOI 10.1371/journal.pone.0206723, PubMed 30412607 -
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
Eur Heart J Cardiovasc Pharmacother, 5 (1), 47-54
DOI 10.1093/ehjcvp/pvy038, PubMed 30247574 -
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
Heart, 105 (3), 235-242
DOI 10.1136/heartjnl-2018-313351, PubMed 30209126 -
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
Eur Heart J Cardiovasc Pharmacother, 5 (4), 210-215
DOI 10.1093/ehjcvp/pvy035, PubMed 30192939 -
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
Eur Heart J Cardiovasc Pharmacother, 5 (1), 12-20
DOI 10.1093/ehjcvp/pvy034, PubMed 30192930 -
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995 -
Critical appraisal of the COMPASS trial
Eur Heart J Cardiovasc Pharmacother, 4 (4), 191-192
DOI 10.1093/ehjcvp/pvy027, PubMed 30113628 -
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Eur Heart J Cardiovasc Pharmacother, 4 (4), 230-236
DOI 10.1093/ehjcvp/pvy028, PubMed 30099530 -
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study
Cardiology, 140 (3), 178-185
DOI 10.1159/000491745, PubMed 30099440 -
Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study
Clin Cardiol, 41 (10), 1322-1327
DOI 10.1002/clc.23043, PubMed 30098028 -
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study
Cardiology, 140 (3), 152-154
DOI 10.1159/000490656, PubMed 30089282 -
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
ESC Heart Fail, 5 (5), 977-984
DOI 10.1002/ehf2.12332, PubMed 30088346 -
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Europace, 21 (2), 192-193
DOI 10.1093/europace/euy174, PubMed 30052888 -
New input on antiplatelet treatment and registry studies
Eur Heart J Cardiovasc Pharmacother, 4 (3), 129-130
DOI 10.1093/ehjcvp/pvy016, PubMed 30052852 -
Peripheral arterial disease and limb salvage: a new arena for the cardiologist
Eur Heart J Cardiovasc Pharmacother, 4 (3), 136-137
DOI 10.1093/ehjcvp/pvy014, PubMed 30052851 -
Author's response to: letter to the editor
Heart Fail Rev, 23 (5), 819
DOI 10.1007/s10741-018-9728-6, PubMed 30043131 -
The burden of heart failure in the general population: a clearer and more concerning picture
J Thorac Dis, 10 (Suppl 17), S1934-S1937
DOI 10.21037/jtd.2018.04.153, PubMed 30023084 -
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (4), 563-568
DOI 10.1016/j.jelectrocard.2018.03.016, PubMed 29996989 -
Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
Eur Radiol, 29 (2), 941-950
DOI 10.1007/s00330-018-5588-7, PubMed 29980929 -
Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
J Am Coll Cardiol, 72 (2), 187-198
DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293 -
The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging
Ann Noninvasive Electrocardiol, 23 (6), e12580
DOI 10.1111/anec.12580, PubMed 29971868 -
Response to the editor
Heart Fail Rev (in press)
DOI 10.1007/s10741-018-9723-y, PubMed 29968222 -
Cardiovascular risk profile at the age of 40-45 in women with previous hyperemesis gravidarum or hypertensive disorders in pregnancy: A population-based study
Pregnancy Hypertens, 12, 129-135
DOI 10.1016/j.preghy.2018.04.013, PubMed 29858105 -
Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Int J Cardiol, 268, 187-192
DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279 -
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 4 (3), 180-188
DOI 10.1093/ehjcvp/pvy015, PubMed 29726985 -
Longitudinal left ventricular function is globally depressed within a week of STEMI
Clin Physiol Funct Imaging, 38 (6), 1029-1037
DOI 10.1111/cpf.12521, PubMed 29701310 -
Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
Clin Appl Thromb Hemost, 24 (7), 1088-1094
DOI 10.1177/1076029618764847, PubMed 29695176 -
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Eur J Vasc Endovasc Surg, 55 (4), 457-464
DOI 10.1016/j.ejvs.2017.08.014, PubMed 29628287 -
Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI
Scand Cardiovasc J, 52 (4), 189-195
DOI 10.1080/14017431.2018.1458145, PubMed 29595340 -
Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants
Scand Cardiovasc J, 52 (3), 156-162
DOI 10.1080/14017431.2018.1453613, PubMed 29569500 -
Cardiovascular pharmacotherapy and real-world data
Eur Heart J Cardiovasc Pharmacother, 4 (2), 65-66
DOI 10.1093/ehjcvp/pvy008, PubMed 29554294 -
How does the TRS 2°P score relate to real-world patients?
Eur Heart J Cardiovasc Pharmacother, 4 (2), 72-74
DOI 10.1093/ehjcvp/pvy004, PubMed 29554293 -
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
Heart Fail Rev, 23 (3), 303-323
DOI 10.1007/s10741-018-9685-0, PubMed 29516230 -
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
Eur Heart J, 39 (19), 1672-1686f
DOI 10.1093/eurheartj/ehy066, PubMed 29509886 -
Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
Eur Heart J Qual Care Clin Outcomes, 2 (1), 52-57
DOI 10.1093/ehjqcco/qcv023, PubMed 29474586 -
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
Am Heart J, 197, 133-141
DOI 10.1016/j.ahj.2017.11.005, PubMed 29447773 -
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Europace, 20 (5), 731-732an
DOI 10.1093/europace/eux373, PubMed 29438514 -
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
J Am Heart Assoc, 7 (3)
DOI 10.1161/JAHA.117.007444, PubMed 29419390 -
Cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 4 (1), 1
DOI 10.1093/ehjcvp/pvx036, PubMed 29315398 -
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Europace, 20 (3), 395-407
DOI 10.1093/europace/eux318, PubMed 29300976 -
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
Eur Heart J, 39 (6), 464-473
DOI 10.1093/eurheartj/ehx730, PubMed 29281086 -
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
Scand Cardiovasc J, 52 (1), 1-3
DOI 10.1080/14017431.2017.1405069, PubMed 29202608 -
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Rev Esp Cardiol (Engl Ed), 70 (12), 1082
DOI 10.1016/j.rec.2017.11.010, PubMed 29198432 -
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!
Cardiology, 139 (1), 37-39
DOI 10.1159/000484345, PubMed 29186706 -
Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events
J Am Heart Assoc, 6 (12)
DOI 10.1161/JAHA.117.006709, PubMed 29180457 -
European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature
Eur Heart J, 38 (44), 3251
DOI 10.1093/eurheartj/ehx619, PubMed 29177414 -
Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction
J Electrocardiol, 51 (2), 195-202
DOI 10.1016/j.jelectrocard.2017.11.002, PubMed 29174706 -
Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
Resuscitation, 122, 41-47
DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294 -
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
Cardiology, 139 (1), 17-24
DOI 10.1159/000481684, PubMed 29141241 -
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
Am Heart J, 193, 46-54
DOI 10.1016/j.ahj.2017.07.015, PubMed 29129254 -
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J, 39 (24), 2274-2281
DOI 10.1093/eurheartj/ehx625, PubMed 29126266 -
Patient engagement
Eur Heart J, 38 (42), 3114-3115
DOI 10.1093/eurheartj/ehx600, PubMed 29121227 -
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
J Am Heart Assoc, 6 (11)
DOI 10.1161/JAHA.117.006513, PubMed 29118031 -
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
Eur Heart J Cardiovasc Imaging, 19 (5), 544-552
DOI 10.1093/ehjci/jex159, PubMed 29106497 -
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (2), 218-223
DOI 10.1016/j.jelectrocard.2017.09.013, PubMed 29103621 -
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin
Stroke, 48 (12), 3266-3273
DOI 10.1161/STROKEAHA.117.017574, PubMed 29089455 -
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Arthritis Res Ther, 19 (1), 232
DOI 10.1186/s13075-017-1439-1, PubMed 29041979 -
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Int J Cardiol, 249, 274-281
DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557 -
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
J Am Coll Cardiol, 70 (14), 1760-1776
DOI 10.1016/j.jacc.2017.08.037, PubMed 28958334 -
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
DOI 10.1038/s41598-017-12372-w, PubMed 28931920 -
Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy
J Electrocardiol, 50 (6), 725-731
DOI 10.1016/j.jelectrocard.2017.08.019, PubMed 28918213 -
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 39 (2), 119-177
DOI 10.1093/eurheartj/ehx393, PubMed 28886621 -
Morphine in acute heart failure
J Thorac Dis, 9 (7), 1851-1854
DOI 10.21037/jtd.2017.06.129, PubMed 28839982 -
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
Data Brief, 14, 197-205
DOI 10.1016/j.dib.2017.07.033, PubMed 28795098 -
Neurohormonal Blockade in Heart Failure
Card Fail Rev, 3 (1), 19-24
DOI 10.15420/cfr.2016:22:2, PubMed 28785471 -
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins
Cardiology, 138 (2), 122-132
DOI 10.1159/000475460, PubMed 28651249 -
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials
Int J Cardiol, 244, 59-66
DOI 10.1016/j.ijcard.2017.06.040, PubMed 28634037 -
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)
Circulation, 136 (13), 1193-1203
DOI 10.1161/CIRCULATIONAHA.117.027252, PubMed 28626088 -
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
Cardiorenal Med, 7 (2), 128-136
DOI 10.1159/000454933, PubMed 28611786 -
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study
J Am Heart Assoc, 5 (6)
DOI 10.1161/JAHA.116.003559, PubMed 28525886 -
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
Eur Heart J Cardiovasc Pharmacother, 4 (2), 82-92
DOI 10.1093/ehjcvp/pvx013, PubMed 28475676 -
Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis
Heart, 103 (18), 1443-1448
DOI 10.1136/heartjnl-2016-310917, PubMed 28455295 -
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Clin Res Cardiol, 106 (9), 711-721
DOI 10.1007/s00392-017-1115-0, PubMed 28434020 -
Automatic identification of variables in epidemiological datasets using logic regression
BMC Med Inform Decis Mak, 17 (1), 40
DOI 10.1186/s12911-017-0429-1, PubMed 28407816 -
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
Int J Cardiol, 238, 97-104
DOI 10.1016/j.ijcard.2017.03.028, PubMed 28342630 -
Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
Eur Heart J Cardiovasc Pharmacother, 3 (3), 147-150
DOI 10.1093/ehjcvp/pvx003, PubMed 28329309 -
Gender differences in the effects of cardiovascular drugs
Eur Heart J Cardiovasc Pharmacother, 3 (3), 163-182
DOI 10.1093/ehjcvp/pvw042, PubMed 28329228 -
Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study
BMC Cardiovasc Disord, 17 (1), 75
DOI 10.1186/s12872-017-0508-3, PubMed 28288586 -
Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography
Eur Radiol, 27 (9), 3934-3941
DOI 10.1007/s00330-017-4770-7, PubMed 28271154 -
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
PLoS One, 12 (3), e0173034
DOI 10.1371/journal.pone.0173034, PubMed 28253327 -
Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images
BMC Med Imaging, 17 (1), 19
DOI 10.1186/s12880-017-0189-5, PubMed 28241751 -
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
PLoS One, 12 (2), e0169830
DOI 10.1371/journal.pone.0169830, PubMed 28225768 -
Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography
Clin Physiol Funct Imaging, 38 (2), 246-253
DOI 10.1111/cpf.12407, PubMed 28168796 -
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
Eur Heart J, 38 (3), 143-153
DOI 10.1093/eurheartj/ehw149, PubMed 28158518 -
New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose
Eur J Intern Med, 40, e11-e12
DOI 10.1016/j.ejim.2017.01.003, PubMed 28087220 -
Comprehensive efforts to increase adherence to statin therapy
Eur Heart J, 38 (32), 2473-2479
DOI 10.1093/eurheartj/ehw628, PubMed 28077470 -
European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition
Eur Heart J Cardiovasc Pharmacother, 3 (1), 3-4
DOI 10.1093/ehjcvp/pvw024, PubMed 28062654 -
Anticoagulation, atherosclerosis, and heart failure
Eur Heart J Cardiovasc Pharmacother, 3 (1), 1-2
DOI 10.1093/ehjcvp/pvw037, PubMed 28062653 -
Hyperemesis gravidarum and long-term mortality: a population-based cohort study
BJOG, 124 (7), 1080-1087
DOI 10.1111/1471-0528.14454, PubMed 27981734 -
'Ten Commandments' of 2016 ESC Guidelines for the management of atrial fibrillation
Eur Heart J, 37 (38), 2853
DOI 10.1093/eurheartj/ehw370, PubMed 27923817 -
Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients
Int J Cardiol, 227, 876-881
DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085 -
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
Eur Heart J, 38 (19), 1455-1462
DOI 10.1093/eurheartj/ehw454, PubMed 27789570 -
Cardiovascular pharmacotherapy
Int J Cardiol, 224, 412-415
DOI 10.1016/j.ijcard.2016.09.065, PubMed 27690338 -
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
Eur Heart J Cardiovasc Pharmacother, 3 (1), 28-36
DOI 10.1093/ehjcvp/pvw031, PubMed 27680880 -
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Heart, 103 (4), 307-314
DOI 10.1136/heartjnl-2016-309832, PubMed 27647168 -
The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!
Eur Heart J Cardiovasc Pharmacother, 2 (4), 207-8
DOI 10.1093/ehjcvp/pvw021, PubMed 27600901 -
Gender differences in the assessment and treatment of myocardial infarction
Tidsskr Nor Laegeforen, 136 (14-15), 1215-22
DOI 10.4045/tidsskr.16.0224, PubMed 27554562 -
Cardiovascular Pharmacotherapy is moving!
Eur Heart J Cardiovasc Pharmacother, 1 (3), 149
DOI 10.1093/ehjcvp/pvv025, PubMed 27533986 -
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother, 1 (2), 86-94
DOI 10.1093/ehjcvp/pvu024, PubMed 27533976 -
European Heart Journal - CVP: what is next?
Eur Heart J Cardiovasc Pharmacother, 1 (2), 73
DOI 10.1093/ehjcvp/pvv009, PubMed 27533970 -
End of story? Studies on prevention of reperfusion injury encounter perpetual defeats
Eur Heart J Cardiovasc Pharmacother, 1 (1), 46-7
DOI 10.1093/ehjcvp/pvu018, PubMed 27533965 -
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
Eur Heart J Cardiovasc Pharmacother, 1 (1), 31-6
DOI 10.1093/ehjcvp/pvu010, PubMed 27533962 -
European Heart Journal - Cardiovascular Pharmacotherapy: a new journal within the European Heart Journal family
Eur Heart J Cardiovasc Pharmacother, 1 (1), 1
DOI 10.1093/ehjcvp/pvu022, PubMed 27533955 -
News from EHJCVP
Eur Heart J Cardiovasc Pharmacother, 2 (3), 141
DOI 10.1093/ehjcvp/pvw010, PubMed 27533754 -
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 2 (2), 108-18
DOI 10.1093/ehjcvp/pvv054, PubMed 27533522 -
Update from EHJ CVP
Eur Heart J Cardiovasc Pharmacother, 2 (2), 77-8
DOI 10.1093/ehjcvp/pvw004, PubMed 27533516 -
Second year of a journal
Eur Heart J Cardiovasc Pharmacother, 2 (1), 1-2
DOI 10.1093/ehjcvp/pvv049, PubMed 27533054 -
Starting up a new Journal within the European Heart Journal Family
Eur Heart J Cardiovasc Pharmacother, 1 (4), 213
DOI 10.1093/ehjcvp/pvv033, PubMed 27532442 -
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiol, 1 (6), 673-81
DOI 10.1001/jamacardio.2016.1829, PubMed 27463942 -
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiol, 1 (2), 126-35
DOI 10.1001/jamacardio.2016.0103, PubMed 27437883 -
Troponin and exercise
Int J Cardiol, 221, 609-21
DOI 10.1016/j.ijcard.2016.06.243, PubMed 27420587 -
Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
J Am Heart Assoc, 5 (6)
DOI 10.1161/JAHA.115.003014, PubMed 27412895 -
Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging
Circ Cardiovasc Imaging, 9 (7)
DOI 10.1161/CIRCIMAGING.115.004376, PubMed 27412659 -
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]
Eur J Heart Fail, 18 (6), 727
DOI 10.1002/ejhf.591, PubMed 27324688 -
Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
BMC Cardiovasc Disord, 16, 115
DOI 10.1186/s12872-016-0283-6, PubMed 27246583 -
A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data
J Cardiovasc Magn Reson, 18 (1), 27
DOI 10.1186/s12968-016-0242-5, PubMed 27145749 -
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials
Cardiovasc Revasc Med, 17 (5), 295-301
DOI 10.1016/j.carrev.2016.03.008, PubMed 27116940 -
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
Eur J Heart Fail, 18 (5), 482-9
DOI 10.1002/ejhf.516, PubMed 27071916 -
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
Eur Heart J, 37 (38), 2869-2878
DOI 10.1093/eurheartj/ehw124, PubMed 27071819 -
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
Eur Heart J Cardiovasc Imaging, 17 (7), 744-53
DOI 10.1093/ehjci/jew027, PubMed 27002140 -
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J, 37 (13), 1015-23
DOI 10.1093/eurheartj/ehv505, PubMed 26984863 -
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
J Am Heart Assoc, 5 (3), e002708
DOI 10.1161/JAHA.115.002708, PubMed 26961520 -
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
Thromb Haemost, 115 (4), 685-711
DOI 10.1160/TH15-09-0703, PubMed 26952877 -
In memoriam Henry Krum, 1958-2015
Cardiology, 134 (2), 107-8
DOI 10.1159/000444294, PubMed 26950607 -
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT
BMC Med Imaging, 16, 19
DOI 10.1186/s12880-016-0124-1, PubMed 26946139 -
Assessment of Right Ventricular Afterload in COPD
COPD, 13 (2), 176-85
DOI 10.3109/15412555.2015.1057275, PubMed 26914261 -
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Eur Heart J, 37 (21), 1671-80
DOI 10.1093/eurheartj/ehw022, PubMed 26903532 -
Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction
Heart, 102 (7), 527-33
DOI 10.1136/heartjnl-2015-308075, PubMed 26783237 -
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
J Am Heart Assoc, 4 (12)
DOI 10.1161/JAHA.115.002015, PubMed 26627878 -
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Am J Cardiol, 116 (12), 1840-4
DOI 10.1016/j.amjcard.2015.09.026, PubMed 26602073 -
Morphine in myocardial infarction: balancing on the tight rope
Eur Heart J, 37 (3), 253-5
DOI 10.1093/eurheartj/ehv546, PubMed 26491111 -
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis
Circ Cardiovasc Imaging, 8 (11), e003644; discussion e003644
DOI 10.1161/CIRCIMAGING.115.003644, PubMed 26489804 -
Morphine in the treatment of acute pulmonary oedema--Why?
Int J Cardiol, 202, 870-3
DOI 10.1016/j.ijcard.2015.10.014, PubMed 26476045 -
Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action
Europace, 18 (1), 1-3
DOI 10.1093/europace/euv318, PubMed 26462701 -
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Eur J Heart Fail, 17 (11), 1144-51
DOI 10.1002/ejhf.419, PubMed 26424212 -
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
Thromb J, 13, 31
DOI 10.1186/s12959-015-0061-1, PubMed 26396552 -
Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr
Am Heart J, 170 (3), 465-70
DOI 10.1016/j.ahj.2015.06.014, PubMed 26385029 -
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial
Eur Heart J, 36 (46), 3268-75
DOI 10.1093/eurheartj/ehv447, PubMed 26371113 -
Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
J Am Heart Assoc, 4 (8), e002049
DOI 10.1161/JAHA.115.002049, PubMed 26304934 -
Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study
Circ Heart Fail, 8 (5), 887-96
DOI 10.1161/CIRCHEARTFAILURE.114.001701, PubMed 26175538 -
Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis
Heart, 101 (19), 1554-61
DOI 10.1136/heartjnl-2015-307815, PubMed 26175478 -
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
Eur Heart J, 36 (46), 3238-49
DOI 10.1093/eurheartj/ehv304, PubMed 26163482 -
Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study
BMC Cardiovasc Disord, 15, 63
DOI 10.1186/s12872-015-0061-x, PubMed 26148508 -
Prevention of cardiovascular disease in rheumatoid arthritis
Autoimmun Rev, 14 (10), 952-69
DOI 10.1016/j.autrev.2015.06.004, PubMed 26117596 -
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome
Heart, 101 (18), 1475-84
DOI 10.1136/heartjnl-2014-307346, PubMed 26109589 -
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
Europace, 17 (8), 1197-214
DOI 10.1093/europace/euv190, PubMed 26105732 -
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
Int J Cardiol, 196, 133-8
DOI 10.1016/j.ijcard.2015.06.006, PubMed 26093527 -
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
Eur Heart J, 37 (9), 747-54
DOI 10.1093/eurheartj/ehv213, PubMed 26077039 -
The National Cardiac Societies of the European Society of Cardiology
Eur Heart J, 36 (21), 1278
DOI 10.1093/eurheartj/ehv091, PubMed 26034059 -
Atherosclerosis: Recent trials, new targets and future directions
Int J Cardiol, 192, 72-81
DOI 10.1016/j.ijcard.2015.05.013, PubMed 26002254 -
The Effects of Climate Change on Cardiac Health
Cardiology, 131 (4), 209-17
DOI 10.1159/000398787, PubMed 25997478 -
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
Eur Heart J, 36 (33), 2239-45
DOI 10.1093/eurheartj/ehv201, PubMed 25971288 -
Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data
Atherosclerosis, 241 (1), 87-91
DOI 10.1016/j.atherosclerosis.2015.04.816, PubMed 25967935 -
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
Eur Heart J, 36 (40), 2677-80
DOI 10.1093/eurheartj/ehv161, PubMed 25948737 -
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis
Ann Intern Med, 163 (1), 40-51
DOI 10.7326/M14-2957, PubMed 25915661 -
How to save six million people per year
Atherosclerosis, 240 (2), 387-8
DOI 10.1016/j.atherosclerosis.2015.04.006, PubMed 25881201 -
Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)
EuroIntervention, 11 (5), 518-24
DOI 10.4244/EIJY15M04_02, PubMed 25868877 -
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis
Int J Cardiol, 186, 104-5
DOI 10.1016/j.ijcard.2015.03.116, PubMed 25828104 -
Increased LV apical untwist during preload reduction in healthy humans: an echocardiographic speckle tracking study during lower body negative pressure
Physiol Rep, 3 (3)
DOI 10.14814/phy2.12330, PubMed 25802362 -
Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study
Eur Heart J Acute Cardiovasc Care, 5 (3), 243-52
DOI 10.1177/2048872615574706, PubMed 25753053 -
Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged
Heart, 101 (9), 692-8
DOI 10.1136/heartjnl-2014-306686, PubMed 25691510 -
High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy
Open Heart, 2 (1), e000152
DOI 10.1136/openhrt-2014-000152, PubMed 25685360 -
Cardiac troponin elevations in acute non-coronary disease: Helpful or not?
Eur Heart J Acute Cardiovasc Care, 4 (5), 429-30
DOI 10.1177/2048872615573921, PubMed 25678669 -
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Am Heart J, 169 (2), 257-265.e1
DOI 10.1016/j.ahj.2014.10.015, PubMed 25641535 -
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials
JACC Cardiovasc Interv, 8 (1 Pt B), 166-174
DOI 10.1016/j.jcin.2014.09.005, PubMed 25616922 -
Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
Vasc Health Risk Manag, 10, 683-9
DOI 10.2147/VHRM.S72764, PubMed 25525366 -
[Morphine in the treatment of acute pulmonary oedema]
Tidsskr Nor Laegeforen, 134 (23-24), 2272-5
DOI 10.4045/tidsskr.14.0359, PubMed 25492336 -
The association between meteorological events and acute heart failure: new insights from ASCEND-HF
Int J Cardiol, 177 (3), 819-24
DOI 10.1016/j.ijcard.2014.11.066, PubMed 25465826 -
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
J Am Coll Cardiol, 64 (21), 2281-93
DOI 10.1016/j.jacc.2014.08.036, PubMed 25456761 -
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy
Clin Chem, 61 (2), 368-78
DOI 10.1373/clinchem.2014.226936, PubMed 25451868 -
Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
Am Heart J, 168 (5), 757-65
DOI 10.1016/j.ahj.2014.07.027, PubMed 25440805 -
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study
Int J Cardiol, 180, 122-8
DOI 10.1016/j.ijcard.2014.11.181, PubMed 25438232 -
Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
Eur J Prev Cardiol, 23 (2), 194-205
DOI 10.1177/2047487314560664, PubMed 25416041 -
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy
Circ Heart Fail, 8 (1), 71-8
DOI 10.1161/CIRCHEARTFAILURE.114.001785, PubMed 25362207 -
Myocardial infarction in Norway in 2013
Tidsskr Nor Laegeforen, 134 (19), 1841-6
DOI 10.4045/tidsskr.14.0804, PubMed 25314984 -
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
Heart, 100 (24), 1946-53
DOI 10.1136/heartjnl-2014-305763, PubMed 25217488 -
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients
JACC Cardiovasc Imaging, 7 (9), 930-9
DOI 10.1016/j.jcmg.2014.05.010, PubMed 25212799 -
Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Chest, 146 (3), 735-761
DOI 10.1378/chest.13-2993, PubMed 25180724 -
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
Chest, 146 (3), 727-734
DOI 10.1378/chest.13-2828, PubMed 25180723 -
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results
Eur Heart J, 36 (2), 112-9
DOI 10.1093/eurheartj/ehu331, PubMed 25179768 -
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up
Circulation, 130 (14), 1139-45
DOI 10.1161/CIRCULATIONAHA.114.009570, PubMed 25161043 -
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
Eur Heart J, 35 (45), 3155-79
DOI 10.1093/eurheartj/ehu298, PubMed 25154388 -
Troponins in heart failure
Clin Chim Acta, 443, 78-84
DOI 10.1016/j.cca.2014.08.016, PubMed 25151947 -
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Europace, 17 (2), 194-206
DOI 10.1093/europace/euu201, PubMed 25149078 -
[Re: Renal sympathetic denervation in treatment-resistant hypertension]
Tidsskr Nor Laegeforen, 134 (15), 1449-50
DOI 10.4045/tidsskr.14.0931, PubMed 25138398 -
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Am J Cardiol, 114 (5), 751-6
DOI 10.1016/j.amjcard.2014.06.006, PubMed 25048345 -
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis
J Am Coll Cardiol, 64 (3), 319-27
DOI 10.1016/j.jacc.2014.03.049, PubMed 25034070 -
Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis
Int J Cardiol, 175 (3), 492-8
DOI 10.1016/j.ijcard.2014.06.013, PubMed 25012498 -
Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
Cytokine, 69 (1), 131-5
DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044 -
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
Eur Heart J, 35 (30), 2001-9
DOI 10.1093/eurheartj/ehu205, PubMed 24904027 -
Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Stroke, 45 (7), 1939-46
DOI 10.1161/STROKEAHA.114.005296, PubMed 24903982 -
Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea
Sleep Med, 15 (7), 762-8
DOI 10.1016/j.sleep.2014.03.008, PubMed 24841106 -
Current role of neprilysin inhibitors in hypertension and heart failure
Pharmacol Ther, 144 (1), 41-9
DOI 10.1016/j.pharmthera.2014.05.002, PubMed 24836726 -
Health-related quality of life after myocardial infarction, does choice of method make a difference?
Scand Cardiovasc J, 48 (4), 216-22
DOI 10.3109/14017431.2014.923581, PubMed 24828790 -
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
Eur Heart J, 35 (37), 2516-23
DOI 10.1093/eurheartj/ehu177, PubMed 24796339 -
Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
J Am Heart Assoc, 3 (2), e000679
DOI 10.1161/JAHA.113.000679, PubMed 24760962 -
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
Mediators Inflamm, 2014, 608414
DOI 10.1155/2014/608414, PubMed 24737925 -
[Final reply: follow the Danish example]
Lakartidningen, 111 (9-10), 405
PubMed 24707558 -
IL-6 signalling in patients with acute ST-elevation myocardial infarction
Results Immunol, 4, 8-13
DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455 -
Comorbidities and polypharmacy
Heart Fail Clin, 10 (2), 367-72
DOI 10.1016/j.hfc.2013.12.001, PubMed 24656112 -
Networks for improving care in patients with acute coronary syndrome: A framework
Acute Card Care, 16 (2), 41-8
DOI 10.3109/17482941.2014.881502, PubMed 24654609 -
[Why all these guidelines?]
Lakartidningen, 111 (5), 129
PubMed 24624760 -
Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
Hypertension, 63 (5), 991-9
DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332 -
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Eur Heart J, 35 (28), 1864-72
DOI 10.1093/eurheartj/ehu046, PubMed 24561548 -
Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade
Fundam Clin Pharmacol, 28 (4), 353-63
DOI 10.1111/fcp.12063, PubMed 24494730 -
The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease
Clin Physiol Funct Imaging, 34 (5), 389-96
DOI 10.1111/cpf.12110, PubMed 24438358 -
[Renal sympathetic denervation in treatment-resistant hypertension]
Tidsskr Nor Laegeforen, 134 (1), 32-6
DOI 10.4045/tidsskr.13.0276, PubMed 24429753 -
"Troponin elevation in coronary ischemia and necrosis"
Curr Atheroscler Rep, 16 (3), 396
DOI 10.1007/s11883-013-0396-7, PubMed 24425063 -
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Europace, 16 (3), 308-19
DOI 10.1093/europace/eut373, PubMed 24351881 -
Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction
Angiology, 65 (10), 932-6
DOI 10.1177/0003319713512720, PubMed 24288363 -
Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima-media thickness
Clin Physiol Funct Imaging, 34 (4), 322-6
DOI 10.1111/cpf.12101, PubMed 24237780 -
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Circulation, 129 (6), 625-34
DOI 10.1161/CIRCULATIONAHA.113.006286, PubMed 24226808 -
Requirements for angiology/vascular medicine
Int Angiol, 32 (6), 608-12
PubMed 24212296 -
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
Eur Heart J, 35 (4), 224-32
DOI 10.1093/eurheartj/eht445, PubMed 24144788 -
Fibrinolytic treatment of ST-elevation myocardial infarction. Update 2014
Hamostaseologie, 34 (1), 47-53
DOI 10.5482/HAMO-13-07-0040, PubMed 24085113 -
New oral anticoagulants--a review
Tidsskr Nor Laegeforen, 133 (18), 1940-5
DOI 10.4045/tidsskr.12.1111, PubMed 24084970 -
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
J Am Coll Cardiol, 63 (1), 52-61
DOI 10.1016/j.jacc.2013.07.093, PubMed 24055845 -
Obstructive sleep apnea: no independent association to troponins
Sleep Breath, 18 (2), 351-8
DOI 10.1007/s11325-013-0892-6, PubMed 24043484 -
[Cardioprotective treatment during adjuvant cancer therapy]
Tidsskr Nor Laegeforen, 133 (17), 1832-6
DOI 10.4045/tidsskr.12.1514, PubMed 24042297 -
The author’s reply
Heart, 100 (1), 81-2
DOI 10.1136/heartjnl-2013-304648, PubMed 24014283 -
Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
PLoS One, 8 (8), e71780
DOI 10.1371/journal.pone.0071780, PubMed 23977143 -
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis
Heart, 100 (1), 28-33
DOI 10.1136/heartjnl-2013-304443, PubMed 23969478 -
[Atrial fibrillation and stroke]
Tidsskr Nor Laegeforen, 133 (14), 1453-7
DOI 10.4045/tidsskr.12.0850, PubMed 23929293 -
Diuretic use in heart failure and outcomes
Clin Pharmacol Ther, 94 (4), 490-8
DOI 10.1038/clpt.2013.140, PubMed 23852396 -
Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure
Hypertension, 62 (3), 526-32
DOI 10.1161/HYPERTENSIONAHA.113.01452, PubMed 23836798 -
Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty
Kardiol Pol, 71 (5), 453-63
DOI 10.5603/KP.2013.0091, PubMed 23788085 -
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
Eur J Clin Pharmacol, 69 (10), 1747-55
DOI 10.1007/s00228-013-1512-x, PubMed 23743778 -
Sick leave and a smoking ban
Eur Heart J, 35 (5), 266-7
DOI 10.1093/eurheartj/eht178, PubMed 23739243 -
Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impact in Diabetics pilot trial
Am J Ther, 21 (6), 482-90
DOI 10.1097/MJT.0b013e31826915ab, PubMed 23698186 -
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure
Circ Heart Fail, 6 (3), 594-605
DOI 10.1161/CIRCHEARTFAILURE.112.000289, PubMed 23694773 -
Prasugrel: the real-life perspective
Circ Cardiovasc Qual Outcomes, 6 (3), 253-4
DOI 10.1161/CIRCOUTCOMES.113.000239, PubMed 23674315 -
Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: a case report
Am J Ther, 21 (6), e229-33
DOI 10.1097/MJT.0b013e31828fdb1c, PubMed 23665886 -
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity—the response
Heart, 99 (13), 969
DOI 10.1136/heartjnl-2013-303771, PubMed 23661637 -
[New European guidelines for acute and chronic heart failure]
Lakartidningen, 110 (13-14), 672-3
PubMed 23634620 -
Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4
Angiology, 65 (5), 443-9
DOI 10.1177/0003319713483000, PubMed 23567479 -
Oxygen therapy in acute coronary syndrome: are the benefits worth the risk?
Eur Heart J, 34 (22), 1630-5
DOI 10.1093/eurheartj/eht110, PubMed 23554440 -
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction
N Engl J Med, 368 (15), 1379-87
DOI 10.1056/NEJMoa1301092, PubMed 23473396 -
Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor
Clin Exp Rheumatol, 31 (3), 415-21
PubMed 23465067 -
Questionable levels of evidence in new atrial fibrillation guidelines? Reply
Europace, 15 (3), 461-2
DOI 10.1093/europace/eus394, PubMed 23430753 -
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply
Europace, 15 (3), 460-1
DOI 10.1093/europace/eus386, PubMed 23430752 -
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
Eur Heart J, 34 (23), 1708-13, 1713a-1713b
DOI 10.1093/eurheartj/eht042, PubMed 23425521 -
Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study
Int J Cardiol, 168 (3), 2322-7
DOI 10.1016/j.ijcard.2013.01.060, PubMed 23416018 -
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
Eur Heart J, 34 (22), 1621-9
DOI 10.1093/eurheartj/eht013, PubMed 23382466 -
Thyroid dysfunction in patients with myocardial infarction with normal coronary arteries
Angiology, 64 (3), 245-6
DOI 10.1177/0003319712471071, PubMed 23299173 -
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
Int J Cardiol, 167 (5), 1772-82
DOI 10.1016/j.ijcard.2012.12.018, PubMed 23298559 -
Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
Cardiology, 123 (4), 240-7
DOI 10.1159/000343622, PubMed 23207160 -
Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial
J Cardiovasc Pharmacol, 61 (3), 250-7
DOI 10.1097/FJC.0b013e31827cb626, PubMed 23188121 -
Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience
Clin Lab, 58 (9-10), 1029-36
DOI 10.7754/Clin.Lab.2012.111206, PubMed 23163120 -
Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF
Eur J Heart Fail, 15 (4), 456-64
DOI 10.1093/eurjhf/hfs188, PubMed 23159547 -
Pharmacological conversion of recent-onset atrial fibrillation: a systematic review
Scand Cardiovasc J Suppl, 47 (1), 2-10
DOI 10.3109/14017431.2012.740572, PubMed 23067130 -
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity
Heart, 99 (1), 30-4
DOI 10.1136/heartjnl-2012-303009, PubMed 23048165 -
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
Atherosclerosis, 225 (1), 160-5
DOI 10.1016/j.atherosclerosis.2012.08.033, PubMed 23014354 -
Third universal definition of myocardial infarction
J Am Coll Cardiol, 60 (16), 1581-98
DOI 10.1016/j.jacc.2012.08.001, PubMed 22958960 -
Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway
Vasc Health Risk Manag, 8, 505-15
DOI 10.2147/VHRM.S33627, PubMed 22956878 -
Third universal definition of myocardial infarction
Circulation, 126 (16), 2020-35
DOI 10.1161/CIR.0b013e31826e1058, PubMed 22923432 -
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association
Europace, 14 (10), 1385-413
DOI 10.1093/europace/eus305, PubMed 22923145 -
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Eur Heart J, 33 (20), 2569-619
DOI 10.1093/eurheartj/ehs215, PubMed 22922416 -
Third universal definition of myocardial infarction
Eur Heart J, 33 (20), 2551-67
DOI 10.1093/eurheartj/ehs184, PubMed 22922414 -
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
Eur Heart J, 33 (21), 2719-47
DOI 10.1093/eurheartj/ehs253, PubMed 22922413 -
STEMI treatment in areas remote from primary PCI centres
EuroIntervention, 8 Suppl P, P44-50
DOI 10.4244/EIJV8SPA8, PubMed 22917789 -
Conclusion
Adv Cardiol, 47, 165
DOI 10.1159/000341140, PubMed 22906911 -
Introduction. Antiplatelet therapy in ACS and A-Fib
Adv Cardiol, 47, 1-4
DOI 10.1159/000338206, PubMed 22906898 -
The German Centre for Cardiovascular Research
Eur Heart J, 33 (9), 1033-36,1036a
PubMed 22893891 -
2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus
Cardiovasc Diabetol, 11, 93
DOI 10.1186/1475-2840-11-93, PubMed 22873202 -
Echogenicity of the carotid intima-media complex and cardiovascular risk factors
Clin Physiol Funct Imaging, 32 (5), 400-3
DOI 10.1111/j.1475-097X.2012.01134.x, PubMed 22856348 -
Regional LV deformation in healthy individuals during isovolumetric contraction and ejection phases assessed by 2D speckle tracking echocardiography
Clin Physiol Funct Imaging, 32 (5), 372-9
DOI 10.1111/j.1475-097X.2012.01139.x, PubMed 22856344 -
Non-alcoholic fatty liver disease and cardiovascular disease
Atherosclerosis, 224 (2), 324-5
DOI 10.1016/j.atherosclerosis.2012.07.018, PubMed 22840429 -
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?
Thromb Haemost, 108 (3), 412-4
DOI 10.1160/TH12-04-0251, PubMed 22836596 -
Can increased arterial stiffness in women relative to men be explained by their progressive loss of gluteofemoral fat?
Atherosclerosis, 224 (2), 320-1
DOI 10.1016/j.atherosclerosis.2012.05.041, PubMed 22800649 -
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
Eur J Heart Fail, 14 (11), 1257-64
DOI 10.1093/eurjhf/hfs110, PubMed 22764184 -
Left atrial systolic force and outcome in asymptomatic mild to moderate aortic stenosis
Echocardiography, 29 (9), 1038-44
DOI 10.1111/j.1540-8175.2012.01744.x, PubMed 22676207 -
Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors
J Rheumatol, 39 (7), 1341-7
DOI 10.3899/jrheum.111401, PubMed 22660798 -
Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events
Hypertension, 60 (1), 90-7
DOI 10.1161/HYPERTENSIONAHA.112.194878, PubMed 22647889 -
Ultrasound and radiology surrogate endpoints in pharmacological studies
Atherosclerosis, 224 (1), 12-24
DOI 10.1016/j.atherosclerosis.2012.03.038, PubMed 22632921 -
Is aortic bioprosthesis degeneration influenced by metabolic factors?
Cardiology, 121 (4), 274-6
DOI 10.1159/000338565, PubMed 22626909 -
Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy
Thromb Res, 130 (3), 495-500
DOI 10.1016/j.thromres.2012.04.016, PubMed 22607887 -
Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study
Am Heart J, 163 (4), 690-6
DOI 10.1016/j.ahj.2012.01.026, PubMed 22520536 -
Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins
Am J Ther, 22 (5), e141-50
DOI 10.1097/MJT.0b013e318245ce94, PubMed 22487773 -
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis
BMC Cardiovasc Disord, 12, 26
DOI 10.1186/1471-2261-12-26, PubMed 22475076 -
[Troponin can be increased in healthy persons following moderate exercise]
Lakartidningen, 109 (1-2), 18
PubMed 22468405 -
Low self-estimated quality of life after myocardial infarction and future cardiovascular risk
Int J Cardiol, 157 (1), 128-9
DOI 10.1016/j.ijcard.2012.03.044, PubMed 22459393 -
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
J Am Coll Cardiol, 59 (13), 1142-9
DOI 10.1016/j.jacc.2011.12.020, PubMed 22440214 -
Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients
Scand J Rheumatol, 41 (3), 240-2
DOI 10.3109/03009742.2012.656698, PubMed 22401496 -
[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]
G Ital Cardiol (Rome), 13 (3), 171-228
DOI 10.1714/1038.11322, PubMed 22395108 -
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study
Am J Hypertens, 25 (6), 644-50
DOI 10.1038/ajh.2012.12, PubMed 22378036 -
Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation
Clin Chim Acta, 413 (9-10), 933-7
DOI 10.1016/j.cca.2012.02.008, PubMed 22366164 -
[How to diagnose a heart attack in 2012?]
Tidsskr Nor Laegeforen, 132 (3), 265-6
DOI 10.4045/tidsskr.11.1367, PubMed 22314724 -
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis
Heart, 98 (5), 377-83
DOI 10.1136/heartjnl-2011-300475, PubMed 22155702 -
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Circulation, 125 (2), 346-53
DOI 10.1161/CIRCULATIONAHA.111.049759, PubMed 22147903 -
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Int J Cardiol, 166 (1), 72-6
DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417 -
Cost effectiveness of drug-eluting stents as compared with bare metal stents in patients with coronary artery disease
Am J Ther, 20 (6), 596-601
DOI 10.1097/MJT.0b013e3182211a01, PubMed 21822114 -
Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)
Am J Cardiol, 108 (4), 541-7
DOI 10.1016/j.amjcard.2011.03.084, PubMed 21624542 -
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)
Am J Cardiol, 106 (11), 1634-9
DOI 10.1016/j.amjcard.2010.07.042, PubMed 21094366 -
Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial
Am J Cardiol, 105 (12), 1802-8
DOI 10.1016/j.amjcard.2010.01.363, PubMed 20538134 -
Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy)
Am J Cardiol, 105 (10), 1456-60
DOI 10.1016/j.amjcard.2009.12.069, PubMed 20451694 -
Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy)
J Hypertens, 28 (2), 377-83
DOI 10.1097/HJH.0b013e328332fa44, PubMed 19844185 -
Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease
Am J Ther, 21 (2), 91-8
DOI 10.1097/MJT.0b013e3181b0a6ff, PubMed 19770797 -
Aortic valve stenosis
Lancet, 373 (9680), 2022-3; author reply 2023
DOI 10.1016/S0140-6736(09)61104-1, PubMed 19524771 -
Left ventricular systolic and diastolic function in asymptomatic patients with moderate aortic stenosis
Am J Cardiol, 102 (7), 897-901
DOI 10.1016/j.amjcard.2008.07.001, PubMed 18805118 -
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
N Engl J Med, 359 (13), 1343-56
DOI 10.1056/NEJMoa0804602, PubMed 18765433 -
Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy)
Am J Cardiol, 101 (4), 510-5
DOI 10.1016/j.amjcard.2007.09.100, PubMed 18312768 -
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study
Am J Cardiol, 99 (7), 970-3
DOI 10.1016/j.amjcard.2006.10.064, PubMed 17398194 -
Hyperlipidaemia and aortic valve disease
Curr Opin Lipidol, 15 (4), 447-51
DOI 10.1097/01.mol.0000137229.00020.fe, PubMed 15243218 -
Percutaneous coronary intervention in the patient on oral anticoagulation
Tidsskr. Nor. Laegeforen., 135 (1), 55
DOI 10.4045/tidsskr.14.1248 -
Intensification of antithrombotic therapy for chronic atherosclerosis
Tidsskr. Nor. Laegeforen., 140 (10), 976-977 -
Calcific Aortic Stenosis Reply
N. Engl. J. Med., 360 (1), 85-86 -
Serum concentration measurements of DOAK drugs Reply
Tidsskr. Nor. Laegeforen., 138 (7), 621 -
Music therapy in invasive cardiac procedures: Expanded perspective
BRIT. J. MUSIC THER., 13594575211039090
DOI 10.1177/13594575211039090 -
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe Covid-19?
Tidsskr. Nor. Laegeforen., 140 (9), 859-860 -
Proper Use of Left Atrial Ejection Force as a Measure of Left Atrial Mechanical Function Reply
Echocardiography-J. Cardiovasc. Ultrasound Allied Tech., 29 (7), 881-882 -
Facilitated music listening: Music therapy in an invasive cardiac procedure
BRIT. J. MUSIC THER., 33 (1), 27-38
DOI 10.1177/1359457519840131 -
Antiplatelet Therapy in ACS and A-Fib Conclusion
Adv.Cardiol., 47, 165 -
Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction"
Circulation, 124 (13), E362-E363
DOI 10.1161/CIRCULATIONAHA.111.045203 -
In memoriam Eivind Berge, MD, PhD, 1964-2020: cardiologist, trialist and hypertension/stroke researcher
J. Hypertens., 38 (6), 1199-1200
DOI 10.1097/HJH.0000000000002488 -
Antiplatelet Therapy in ACS and A-Fib Introduction
Adv.Cardiol., 47, 1-4 -
Female hearts A medical textbook about common heart disease
Tidsskr. Nor. Laegeforen., 136 (4), 333
DOI 10.4045/tidsskr.15.1299